Você procurou por: codon optimized (Inglês - Maltês)

codon
kodon

termination codon
kodon ta' terminazzjoni

raltegravir was administered with an optimized background regimen.
raltegravir ingħata b’reġim fl-isfond ottimizzat li inkludiet lopinavir flimkien ma’ ritonavir f’żewġ terzi tal-pazjenti.

reintegration with optimized integration parameters should be possible.
reintegrazzjoni bil-parametri ta' integrazzjoni ideali għandu jkun possibbli.

finally, electronic possibilities for optimized interaction will also be investigated.
fl-aħħarnett, il-possibilitajiet elettroniċi għall-aħjar interazzjoni se jiġu investigati wkoll.

a nonsense mutation in dna results in a premature stop codon within an mrna.
mutazzjoni nonsense fir-riżultati tad-dna fi stop codon prematur f’mrna.

whereas practices causing medical exposure need to be carried out in optimized radiation protection conditions;
billi l-prattiċi li jikkawżaw esponiment mediku għandhom iseħħu f'kondizzjonijiet ottimizzati ta' protezzjoni mir-radjazzjoni;

alternatively, the recommended mobile phase composition can be optimized in order to obtain the required separation.
inkella, il-kompożizzjoni tal-fażi mobbli rakkommandata tista' tkun imtejba sabiex tinkiseb is-separazzjoni meħtieġa.

this premature stop codon in the mrna causes disease by terminating translation before a full-length protein is generated.
dan l-istop codon prematur fl-mrna jikkawża mard billi jittermina l-qlib qabel ma tiġi ġġenerata proteina b’tul sħiħ.

in those patients already taking an optimized dose of vardenafil, alpha-blocker therapy should be initiated at the lowest dose.
f’dawk il-pazjenti li diġa’ qed jieħdu doża ottimizzata ta’ vardenafil, kura b’alfa-blockers għandha tinbeda bl-inqas doża.

preclinical data generated in biochemical assays demonstrated that dabrafenib inhibits braf kinases with activating codon 600 mutations (table 5).
tagħrif prekliniku ġġenerata f’analiżi bijokimika wera li dabrafenib jinibixxi kinases braf mal- attivazzjoni tal-mutazzjonijiet ta’ codon 600 (tabella 5).

additional mutations in kras and nras at exon 3 (codon 59) were subsequently identified (n = 7).
imbagħad kienu identifikati mutazzjonijiet addizzjonali fi kras u nras f’exon 3 (kodon 59) (n = 7).

different types of adsorption methods and optimized scrubbing systems with mixtures of activated charcoal, open hearth coal, lime and limestone solutions in fixed bed, moving bed and fluidised bed reactors.
tipi differenti ta' metodi ta' assorbiment u sistemi sfruttati ta' tagħrik b'taħliti ta' faħam tal-kannol attivat, faħam tal-fuklar miftuħ, soluzzjonijiet ta' ġir u ġebla tal-franka f'reatturi ta' qiegħ fiss, qiegħ jiċċaqlaq u qiegħ li għandu karatteristiċi ta' fluwidu.

the viking-4 study examined dolutegravir (plus optimized background therapy) in subjects with primary genotypic resistance to inis at screening in 30 subjects.
l-istudju viking-4 eżamina lil dolutegravir (flimkien ma’ terapija ottimizzata ta’ sfond) f’individwi b’reżistenza ġenotipika primarja għal inis fl-iskrining fi 30 individwu.

member states shall establish a system for regular inspection of medium- and large-size heating and air-conditioning systems so that their energy performance is monitored and optimized.
l-istati membri għandhom jistabbilixxu sistema għall-ispezzjoni regolari tas-sistemi tal-arja kkundizzjonata mdaqqsin u kbar biex il-prestazzjoni tal-enerġija tagħhom tkun immonitorjata u ottimizzata.

a reduced virological response was observed in patients with viral strains harbouring two or more mutations at hiv protease codons 33, 82, 84 or 90, and not receiving new enfuvirtide.
tnaqqis fir-rispons viroloġiku ġie osservat f’pazjenti b’razez virali li għandhom żewġ mutazzjonijiet jew aktar fil-codons tal-protease ta’ hiv 33, 82, 84 jew 90, u li mhux qed jirċievu enfuvirtide ġdid.